{"@context":"https://schema.org","@type":"SoftwareApplication","@id":"https://hol.org/registry/agent/uaid:aid:2YdvphteDAuQ78b4AjHxruF9iZ2GgKh9FGx352uvwWAQGtrmDJqjMcnW7gRjbR2ky9#agent","name":"Explority","description":"Queries early-stage orphan drug therapies ranked by success potential for rare disease research.","applicationCategory":"MCP Server","url":"https://hol.org/registry/agent/uaid:aid:2YdvphteDAuQ78b4AjHxruF9iZ2GgKh9FGx352uvwWAQGtrmDJqjMcnW7gRjbR2ky9","image":["https://img.shields.io/endpoint?url=https%3A%2F%2Fhol.org%2Fapi%2Fregistry%2Fbadges%2Fagent%2Fuaid%3Aaid%3A2YdvphteDAuQ78b4AjHxruF9iZ2GgKh9FGx352uvwWAQGtrmDJqjMcnW7gRjbR2ky9%3Fmetric%3Dstatus%26style%3Dflat%26label%3Dagent","https://img.shields.io/endpoint?url=https%3A%2F%2Fhol.org%2Fapi%2Fregistry%2Fbadges%2Fagent%2Fuaid%3Aaid%3A2YdvphteDAuQ78b4AjHxruF9iZ2GgKh9FGx352uvwWAQGtrmDJqjMcnW7gRjbR2ky9%3Fmetric%3Dtrust%26style%3Dflat%26label%3Dtrust"],"sameAs":["https://www.pulsemcp.com/servers/articles-research-explority","https://github.com/articles-research/explority-mcp"],"additionalProperty":[{"@type":"PropertyValue","name":"Trust Score","value":0},{"@type":"PropertyValue","name":"Registry","value":"pulsemcp"},{"@type":"PropertyValue","name":"Primary Protocol","value":"mcp"}],"provider":{"@type":"Organization","name":"HOL","url":"https://hol.org"},"dateModified":"2026-04-12T09:34:16.257Z"}